期刊文献+

注射用灯盏花素与注射用转化糖的配伍稳定性考察 被引量:4

Study of Compatible Stability of Breviscapine for Injection and Invert Sugar for Injection
下载PDF
导出
摘要 目的考察注射用灯盏花素与注射用转化糖在0.9%氯化钠注射液中的稳定性并进行分析。方法观察并测定灯盏花素与转化糖在0.9%氯化钠注射液中配伍后室温放置6 h内的微粒、外观及pH,并采用高效液相色谱法测定配伍液室温放置6 h内的含量变化。结果与配伍0 h比较,配伍液放置6 h内的外观、色泽及含量均无明显变化,pH略有变化,微粒不符合2010年版《中国药典》规定。配伍液中灯盏花乙素含量在6 h内保持在95%以上。结论注射用灯盏花素与注射用转化糖在0.9%氯化钠注射液中不宜配伍。 Objective To investigate and analyze the stability of Breviseapine for Injection and Invert Sugar for Injection in the combi- nation of 0.9 % Sodium Chloride Injection. Methods The microparticles, external appearance and pH value of the compatible mixture solution placed in the room temperature for 6 h were measured. The content change of compatible solution placed in the room tempera- ture for 6 h was determined by HPLC. Results No significant differences in the appearance,color and contents within 6 h after mixing were noted between 0 h and within 6 h for the mixture, the pH value had slight change and the microparticles were inconformity with the stipulation in the China Pharmacopeia (edition 2010). The content of breviscapine in the compatible solution maintained above 95% within 6 h. Conclusion Breviscapine for Injection and Invert Sugar for Injection are inappropriately compatible with 0. 9 % Sodium Chloride Injection.
出处 《中国药业》 CAS 2013年第10期17-18,共2页 China Pharmaceuticals
基金 云南省教育厅科学研究基金项目 项目编号:2010Y178
关键词 灯盏花素 灯盏花乙素 转化糖 配伍 稳定性 breviscapine scutellarin invert sugar compatibility stability
  • 相关文献

参考文献3

二级参考文献19

共引文献42

同被引文献31

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部